Capital Fund Management (CFM)’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-175,225
| Closed | -$3.3M | – | 1101 |
|
|
2024
Q4 | $3.3M | Buy |
175,225
+45,016
| +35% | +$848K | 0.01% | 488 |
|
|
2024
Q3 | $1.96M | Buy |
+130,209
| New | +$1.96M | 0.01% | 513 |
|
|
2021
Q1 | – | Sell |
-70,827
| Closed | -$4.24M | – | 802 |
|
|
2020
Q4 | $4.24M | Buy |
70,827
+47,504
| +204% | +$2.84M | 0.04% | 200 |
|
|
2020
Q3 | $1.4M | Buy |
23,323
+311
| +1% | +$18.7K | 0.02% | 325 |
|
|
2020
Q2 | $1.21M | Sell |
23,012
-13,627
| -37% | -$715K | 0.02% | 286 |
|
|
2020
Q1 | $1.23M | Buy |
36,639
+8,903
| +32% | +$299K | 0.02% | 357 |
|
|
2019
Q4 | $1.26M | Buy |
+27,736
| New | +$1.26M | 0.01% | 458 |
|
|
2019
Q1 | – | Sell |
-66,122
| Closed | -$2.85M | – | 1069 |
|
|
2018
Q4 | $2.85M | Buy |
66,122
+44,000
| +199% | +$1.89M | 0.03% | 303 |
|
|
2018
Q3 | $1.09M | Buy |
22,122
+15,632
| +241% | +$768K | 0.01% | 566 |
|
|
2018
Q2 | $208K | Sell |
6,490
-211
| -3% | -$6.76K | ﹤0.01% | 848 |
|
|
2018
Q1 | $209K | Buy |
+6,701
| New | +$209K | ﹤0.01% | 804 |
|
|
2017
Q3 | – | Sell |
-5,351
| Closed | -$255K | – | 996 |
|
|
2017
Q2 | $255K | Sell |
5,351
-1,236
| -19% | -$58.9K | ﹤0.01% | 688 |
|
|
2017
Q1 | $300K | Buy |
+6,587
| New | +$300K | ﹤0.01% | 746 |
|
|
2016
Q4 | – | Sell |
-38,346
| Closed | -$1.31M | – | 1056 |
|
|
2016
Q3 | $1.31M | Buy |
+38,346
| New | +$1.31M | 0.01% | 479 |
|
|
2015
Q2 | – | Sell |
-76,297
| Closed | -$6.78M | – | 869 |
|
|
2015
Q1 | $6.78M | Sell |
76,297
-5,800
| -7% | -$515K | 0.09% | 136 |
|
|
2014
Q4 | $7.28M | Buy |
+82,097
| New | +$7.28M | 0.09% | 152 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 890 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 991 |
|